Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Chemical Biology & Drug Design|April 19, 2017
A field-based disparity analysis of new 1,2,5-oxadiazole derivatives endowed with antiproliferative activityFederica Porta, Arianna Gelain, Daniela Barlocco, et al.Archiv Der Pharmazie|February 22, 2003
Novel 3-arylamino- and 3-cycloalkylamino-5, 6-diphenyl-pyridazines active as ACAT inhibitorsLucio Toma, Maria Paola Giovannoni, Claudia Vergelli, et al.Molecules (Basel, Switzerland)|June 24, 2018
New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling StudiesElena Pini, Giulio Poli, Tiziano Tuccinardi, et al.Journal of Medicinal Chemistry|April 2, 2004
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptorAmedeo Leonardi, Daniela Barlocco, Federica Montesano, et al.Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Isolation and pharmacological activities of the Tecoma stans alkaloidsLuca Costantino, Laura Raimondi, Renato Pirisino, et al.Journal of Medicinal Chemistry|September 29, 2006
Antibacterial agent discovery using thymidylate synthase biolibrary screeningM Paola Costi, Arianna Gelain, Daniela Barlocco, et al.European Journal of Medicinal Chemistry|June 26, 2018
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agentsLaurent R Chiarelli, Matteo Mori, Daniela Barlocco, et al.European Journal of Medicinal Chemistry|March 22, 2017
An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory propertiesFederica Porta, Giorgio Facchetti, Nicola Ferri, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|March 21, 2019
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agentsLaurent R Chiarelli, Matteo Mori, Giangiacomo Beretta, et al.Journal of Medicinal Chemistry|June 26, 2007
Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptorsWilliam H Bunnelle, Jerome F Daanen, Keith B Ryther, et al.Pageof 4